Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.

How Condition-Specific Stories Fuel Engagement in Social Health

August 15, 2022

Impactful patient leader stories supported by active moderation creates ongoing, condition-specific engagement, and ultimately, trust in social health.

Rise of Influencer Marketing: Patient Leaders Bring Value to Campaigns

July 26, 2022

Influencer marketing campaigns with patient leaders represent a significant opportunity to reach socially engaged, difficult-to-reach health audiences.

Building Insights for Patient Focused Drug Development: Understanding Patient Desires and Barriers

July 12, 2022

The COVID-19 pandemic continues to revolutionize the role of the patient voice in drug development and clinical trial creation and execution.

No Vacation from Condition Management: What Summer Means for Patients & Pharma

July 11, 2022

Patient perspectives on managing chronic condition(s) during the summer can help pharma marketers craft accurate, authentic, and season-specific messaging.

The Role of Social Health in Treating Cancer as a Chronic Condition

February 27, 2023

Survey findings demonstrate the critical role of ongoing social health support for people living with – and beyond – cancer.

Understanding Rare Conditions: The Multifaceted Financial Impact

January 26, 2023

More than a third of Health Union’s Myasthenia Gravis In America 2022 survey respondents said their condition has negatively impacted their finances.

Bringing Patient Centricity to Life: Health Union’s Social Health Network

December 7, 2022

Health Union’s Social Health Network builds health leaders into confident and trustworthy partners for the healthcare industry. Here’s why that matters.

Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience

November 30, 2022

Two health leaders share wins, challenges and opportunities they’ve faced as patient and caregiver to help pharma improve the chronic condition experience.

Healthcare Industry Thought Leadership

Contact